PC945, a Novel Inhaled Antifungal Agent, for the Treatment of Respiratory Fungal Infections

Disease due to pulmonary Aspergillus infection remains a significant unmet need, particularly in immunocompromised patients, patients in critical care and those with underlying chronic lung diseases. To date, treatment using inhaled antifungal agents has been limited to repurposing available systemi...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:J Fungi (Basel)
Main Authors: Murray, Alison, Cass, Lindsey, Ito, Kazuhiro, Pagani, Nicole, Armstrong-James, Darius, Dalal, Paras, Reed, Anna, Strong, Pete
Format: Artigo
Jezik:Inglês
Izdano: MDPI 2020
Teme:
Review
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC7765807/
https://ncbi.nlm.nih.gov/pubmed/33348852
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/jof6040373
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki